Recruiting Paroxysmal Nocturnal Hemoglobinuria Studies in Seattle
About Paroxysmal Nocturnal Hemoglobinuria Clinical Trials in Seattle
Paroxysmal nocturnal hemoglobinuria (PNH) is a rare, acquired blood disease where the immune system destroys red blood cells, causing dark-colored urine, fatigue, and blood clots. It is caused by a genetic mutation in blood stem cells. Treatment includes complement inhibitors like eculizumab.
There are currently 1 paroxysmal nocturnal hemoglobinuria clinical trials recruiting participants in Seattle, WA. These studies are seeking a combined 32 participants. Research is being sponsored by Lakefront Biotherapeutics West LLC. Clinical trial participation is free and participants receive study-related medical care at no cost.
Paroxysmal Nocturnal Hemoglobinuria Clinical Trials in Seattle — FAQ
Are there paroxysmal nocturnal hemoglobinuria clinical trials in Seattle?
Yes, there are 1 paroxysmal nocturnal hemoglobinuria clinical trials currently recruiting in Seattle, WA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Seattle?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Seattle research site will contact you about next steps.
Are clinical trials in Seattle free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Seattle studies also compensate for your time and travel.
What paroxysmal nocturnal hemoglobinuria treatments are being tested?
The 1 active trials in Seattle are testing new therapies including novel drugs, biologics, and treatment approaches for paroxysmal nocturnal hemoglobinuria.
Data updated October 15, 2026 from ClinicalTrials.gov